L.L.C | Jotup

Air Methods Successfully Completes Financial Restructuring

Retrieved on:

木曜日, 12月 28, 2023

Air Methods, Atmosphere of Earth, Weil, Gotshal & Manges, Lazard, Alvarez and Marsal, Corporate action, Growth, L.L.C, Patient, Financial adviser

DENVER, Dec. 28, 2023 (GLOBE NEWSWIRE) -- Air Methods Corporation (“Air Methods” or the “Company”), the leading air medical service provider in the U.S., announced today that it has successfully emerged from Chapter 11 with significantly reduced debt and increased liquidity that positions the Company for long-term success.

Key Points:

DENVER, Dec. 28, 2023 (GLOBE NEWSWIRE) -- Air Methods Corporation (“Air Methods” or the “Company”), the leading air medical service provider in the U.S., announced today that it has successfully emerged from Chapter 11 with significantly reduced debt and increased liquidity that positions the Company for long-term success.
Air Methods is moving forward as an industry leader in air medical services and as an integral link between the nation’s top healthcare facilities and people in rural and remote communities.
We are well-positioned for long-term success and excited about the opportunities ahead.”
As a result of the restructuring process, Air Methods reduced its total debt by approximately $1.7 billion.
“We also appreciate the strong support from our financial stakeholders, who share our confidence in Air Methods’ future.”
Weil, Gotshal & Manges LLP served as legal advisor, Lazard served as financial advisor, and Alvarez & Marsal served as restructuring advisor to Air Methods.

Dada Announces Certain Management Changes

Retrieved on:

火曜日, 12月 19, 2023

Prior to his current role, he served as Chief Financial Officer of JD Logistics, Inc. Mr. Shan joined JD.com in December 2021.

Key Points:

Prior to his current role, he served as Chief Financial Officer of JD Logistics, Inc. Mr. Shan joined JD.com in December 2021.
Mr. Mao received his bachelor’s degree from Beijing Language and Culture University and is a certified public accountant in China.
I wish them all the best,” said Mr. Jeff Huijian He, President of Dada.
“I’m thrilled to welcome Mr. Shan as Chairman and Mr. Mao as our CFO.”

Air Methods Receives Court Approval for Financial Restructuring Plan

Retrieved on:

水曜日, 12月 6, 2023

Air Methods, Health, Plan, Bankruptcy, Atmosphere of Earth, Court, Weil, Gotshal & Manges, Lazard, Alvarez and Marsal, Growth, L.L.C, Patient, United States bankruptcy court

DENVER, Dec. 06, 2023 (GLOBE NEWSWIRE) -- Air Methods Corporation (“Air Methods” or the “Company”), the leading air medical service provider in the U.S., announced today that the U.S. Bankruptcy Court for the Southern District of Texas (the “Court”) confirmed the Company’s prepackaged Plan of Reorganization (the “Plan”).

Key Points:

DENVER, Dec. 06, 2023 (GLOBE NEWSWIRE) -- Air Methods Corporation (“Air Methods” or the “Company”), the leading air medical service provider in the U.S., announced today that the U.S. Bankruptcy Court for the Southern District of Texas (the “Court”) confirmed the Company’s prepackaged Plan of Reorganization (the “Plan”).
Air Methods, which has continued to operate normally throughout the court-supervised restructuring process, expects to emerge from Chapter 11 before the end of the year.
“We appreciate the support of our key financial stakeholders, which has enabled us to reach this milestone on an expedited basis,” said Williams.
Weil, Gotshal & Manges LLP is serving as legal advisor, Lazard is serving as financial advisor and Alvarez & Marsal is serving as restructuring advisor to Air Methods.

RGC Resources, Inc. Raises Annual Dividend to $0.80 per Share

Retrieved on:

火曜日, 11月 28, 2023

MVP, L.L.C

The indicated annual dividend is $0.80 per share, a $0.01 or 1.3% per share increase over the prior annual level.

Key Points:

The indicated annual dividend is $0.80 per share, a $0.01 or 1.3% per share increase over the prior annual level.
The Company has now increased the annual dividend 20 consecutive years.
Paul Nester, CEO of RGC Resources, Inc., stated, “The Roanoke Gas utility continues to deliver solid operational and financial performance.
This dividend increase, our 20th annual increase, reflects our commitment to deliver long-term shareholder value.” The dividend will be paid on February 1, 2024 to shareholders of record on January 17, 2024.

Playtech Partners with Boyd Interactive to Launch Games for Stardust Online Casinos in the United States

Retrieved on:

水曜日, 12月 20, 2023

Partnership, Acquisition, Boyd Gaming, Stardust, Growth, L.L.C, Deity

("Boyd Interactive"), the interactive gaming arm of Boyd Gaming Corporation.

Key Points:

("Boyd Interactive"), the interactive gaming arm of Boyd Gaming Corporation.
Under this new partnership, Playtech will supply a wide array of iCasino slots and table games, as well as Live Casino games, to Boyd Interactive's Stardust-branded player-facing online casinos in the United States.
Boyd's 2022 acquisition of Boyd Interactive (formerly Pala Interactive) and its spring launch of Stardust online casinos in Pennsylvania and New Jersey showcase Boyd's commitment to delivering unparalleled experiences to their valued patrons.
By combining Playtech's industry-leading content with Boyd Interactive's commitment to excellence, the Stardust online casinos are poised to further enhance the online gaming experience for players across Pennsylvania and New Jersey.

Augmedix Announces Pricing of Upsized Public Offering of 6,250,000 Shares of Common Stock

Retrieved on:

木曜日, 11月 16, 2023

Sale, Research, William Blair & Company, Telephone, SAN, Attention, Security (finance), Form, Investment, Acceleration, Evercore, Public expenditure, Marketing, Prospectus, Equity capital markets, Life insurance, L.L.C

The offering was upsized from 5,500,000 shares of common stock.

Key Points:

The offering was upsized from 5,500,000 shares of common stock.
The gross proceeds to Augmedix from this offering are expected to be $25 million, before deducting the underwriting discounts and commissions and other estimated offering expenses payable by Augmedix.
In addition, Augmedix granted the underwriters a 30-day option to purchase an additional 937,500 shares of its common stock.
All of the shares to be sold in the proposed offering will be sold by Augmedix.

Augmedix Announces Proposed Public Offering of 5,500,000 Shares of Common Stock

Retrieved on:

水曜日, 11月 15, 2023

SAN FRANCISCO, Nov. 15, 2023 (GLOBE NEWSWIRE) -- Augmedix, Inc. (Nasdaq: AUGX) (“Augmedix”), a healthcare technology company that delivers industry-leading ambient medical documentation and data solutions, today announced that it has commenced an underwritten public offering of 5,500,000 shares of its common stock.

Key Points:

SAN FRANCISCO, Nov. 15, 2023 (GLOBE NEWSWIRE) -- Augmedix, Inc. (Nasdaq: AUGX) (“Augmedix”), a healthcare technology company that delivers industry-leading ambient medical documentation and data solutions, today announced that it has commenced an underwritten public offering of 5,500,000 shares of its common stock.
Augmedix intends to grant the underwriters a 30-day option to purchase an additional 15% of the shares of its common stock offered in the public offering.
All of the shares to be sold in the proposed offering will be sold by Augmedix.
A preliminary prospectus supplement and accompanying base prospectus relating to the offering and the shares of common stock being offered will be filed with the SEC.

Granite Creek Capital Partners Announces Acquisition of NYP Corp.

Retrieved on:

火曜日, 11月 14, 2023

Acquisition, NYP, Growth, Knowledge, Management, Granite Creek, L.L.C

CHICAGO and ELIZABETH, N.J., Nov. 14, 2023 (GLOBE NEWSWIRE) -- Granite Creek Capital Partners , L.L.C., a private investment firm based in Chicago, today announced its acquisition of NYP, LLC, d/b/a NYP Corp. (“NYP” or the “Company”), a New Jersey-based value-added packaging manufacturer and distributor focused on the wholesale nursery, agricultural, and industrial markets.

Key Points:

CHICAGO and ELIZABETH, N.J., Nov. 14, 2023 (GLOBE NEWSWIRE) -- Granite Creek Capital Partners , L.L.C., a private investment firm based in Chicago, today announced its acquisition of NYP, LLC, d/b/a NYP Corp. (“NYP” or the “Company”), a New Jersey-based value-added packaging manufacturer and distributor focused on the wholesale nursery, agricultural, and industrial markets.
Since its humble beginnings in burlap packaging in 1946, NYP has grown and thrived under multiple generations of family management.
“NYP is deeply committed to its customers, employees, and other partners,” said Dahl.
In conjunction with Granite Creek’s investment in NYP, Granite Creek Partner Jim Clark and Director Andrew Kearney have joined NYP’s board of directors.

Carlyle Secured Lending, Inc. Prices Public Offering of 8.20% Notes Due 2028

Retrieved on:

月曜日, 11月 13, 2023

Sale, UBS, SEC filing, Note, L.L.C, Prospectus, File, Communication, Security (finance)

NEW YORK, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Carlyle Secured Lending, Inc. (Nasdaq: CGBD) (the "Company") today announced that it has priced an underwritten public offering of $75.0 million aggregate principal amount of 8.20% unsecured notes due 2028 (the "Notes").

Key Points:

NEW YORK, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Carlyle Secured Lending, Inc. (Nasdaq: CGBD) (the "Company") today announced that it has priced an underwritten public offering of $75.0 million aggregate principal amount of 8.20% unsecured notes due 2028 (the "Notes").
The Company also granted the underwriters a 30-day option to purchase up to an additional $10.0 million aggregate principal amount of the Notes, solely to cover overallotments, if any.
The offering is expected to close on November 20, 2023, subject to customary closing conditions.
The offering is being conducted as a public offering under the Company's effective shelf registration statement filed with the SEC (File No.

Vaccinex Reports Third Quarter 2023 Financial Results and Provides Corporate Update

Retrieved on:

月曜日, 11月 13, 2023

ROCHESTER, N.Y., Nov. 13, 2023 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage biotechnology company pioneering a differentiated approach to treating neurodegenerative disease and cancer through the inhibition of SEMA4D, today announced financial results for the third quarter ended September 30, 2023 and provided a corporate update on progress in key programs.

Key Points:

ROCHESTER, N.Y., Nov. 13, 2023 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage biotechnology company pioneering a differentiated approach to treating neurodegenerative disease and cancer through the inhibition of SEMA4D, today announced financial results for the third quarter ended September 30, 2023 and provided a corporate update on progress in key programs.
The potential impact of the AD program on Vaccinex valuation and financial resources make this Vaccinex’s most important near-term catalyst.
On August 22, 2023, Vaccinex completed a Private Placement and issued approximately 0.20 million shares1 of common stock for aggregate proceeds of $0.7 million.
Similarly, on September 22, 2023, Vaccinex completed a Private Placement and issued approximately 0.25 million shares of common stock for aggregate proceeds of $0.6 million.